November 08, 2010
Antibiotic resistance has gotten a lot of attention lately, and two recent stories have prominently featured the work of the Center for Disease Dynamics, Economics & Policy.
First, take a look at this article in the New York Times on the debate over subsidies for new antibiotic development: Antibiotics Research Subsides Weighed by U.S.
Then head over to Science Magazine for a discussion of our forthcoming Antibiotic Resistance Index: A Dow Jones for Drug Resistance.
photo credit: Flickr: Terretta
